title: Adverse effects of molgramostim in marrow transplant recipients.
authors.affiliation: University of Texas M.D. Anderson Cancer Center, Division of Pharmacy, Houston 77030.
authors.forename: C
authors.initials: C
authors.lastname: Ippoliti
authors.forename: D
authors.initials: D
authors.lastname: Przepiorka
authors.forename: T
authors.initials: T
authors.lastname: Smith
authors.forename: S
authors.initials: S
authors.lastname: Maiese
authors.forename: S
authors.initials: S
authors.lastname: Giralt
authors.forename: B S
authors.initials: BS
authors.lastname: Andersson
authors.forename: A B
authors.initials: AB
authors.lastname: Deisseroth
authors.forename: R E
authors.initials: RE
authors.lastname: Champlin
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim